Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Another legislative vehicle fine-tuning the contentious 340B drug discount program has been introduced by a bipartisan group of senators, this time with language directing the administration not to | The SUSTAIN 340B Act introduced Wednesday would bring hospital-backed changes, like a clearinghouse to handle improper discounts, and codifies longstanding grey areas in the contentious subsidy program.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

The Health Resources & Services Administration has unveiled its formal plans for a revised version of its contentious 340B Rebate…

After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has released…

An appellate court panel ruled Tuesday that drug manufacturers may not impose 340B rebates without approval from the U.S.…

HRSA unveils revised 340B rebate pilot letting drugmakers deny rebates for some drugs.

The Centers for Medicare and Medicaid Services’ recent proposal to overhaul Medicare’s reimbursement rates for 340B drugs will be…

The Trump administration is revising its rebate pilot for the 340B drug discount program, angering hospitals.